292 related articles for article (PubMed ID: 21412181)
1. Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab.
Lee JS; Wang J; Martin M; Germer S; Kenwright A; Benayed R; Spleiss O; Platt A; Pilson R; Hemmings A; Weinblatt ME; Kaplowitz N; Krasnow J
Pharmacogenet Genomics; 2011 Jul; 21(7):365-74. PubMed ID: 21412181
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms.
Mori S; Terada K; Ueki Y
Mod Rheumatol; 2012 Aug; 22(4):515-23. PubMed ID: 21993917
[TBL] [Abstract][Full Text] [Related]
3. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.
Maruo Y; Nakahara S; Yanagi T; Nomura A; Mimura Y; Matsui K; Sato H; Takeuchi Y
J Gastroenterol Hepatol; 2016 Feb; 31(2):403-8. PubMed ID: 26250421
[TBL] [Abstract][Full Text] [Related]
4. Role of co-inherited Gilbert syndrome on hyperbilirubinemia in Indian beta thalassemia patients.
Dabke PS; Colah RB; Ghosh KK; Nadkarni AH
Hematology; 2014 Oct; 19(7):388-92. PubMed ID: 24620945
[TBL] [Abstract][Full Text] [Related]
5. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.
Kadakol A; Ghosh SS; Sappal BS; Sharma G; Chowdhury JR; Chowdhury NR
Hum Mutat; 2000 Oct; 16(4):297-306. PubMed ID: 11013440
[TBL] [Abstract][Full Text] [Related]
6. Influence of UGT1A1 promoter polymorphism, α-thalassemia and β
Batista JVGF; Arcanjo GS; Batista THC; Sobreira MJ; Santana RM; Domingos IF; Hatzlhofer BL; Falcão DA; Pereira-Martins DA; Oliveira JM; Araujo AS; Laranjeira LPM; Medeiros FS; Albuquerque FP; Albuquerque DM; Santos MN; Hazin MF; Dos Anjos AC; Costa FF; Araujo AS; Lucena-Araujo AR; Bezerra MA
Ann Hematol; 2021 Apr; 100(4):903-911. PubMed ID: 33523291
[TBL] [Abstract][Full Text] [Related]
7. A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease.
de Vries HS; Te Morsche RH; Jenniskens K; Peters WH; de Jong DJ
J Crohns Colitis; 2012 Jun; 6(5):597-602. PubMed ID: 22398043
[TBL] [Abstract][Full Text] [Related]
8. Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.
Rodrigues C; Vieira E; Santos R; de Carvalho J; Santos-Silva A; Costa E; Bronze-da-Rocha E
Blood Cells Mol Dis; 2012 Mar; 48(3):166-72. PubMed ID: 22325916
[TBL] [Abstract][Full Text] [Related]
9. A homozygous mutation in UGT1A1 exon 5 may be responsible for persistent hyperbilirubinemia in a Japanese girl with Gilbert's syndrome.
Nakagawa T; Mure T; Yusoff S; Ono E; Kusuma Harahap IS; Morikawa S; Morioka I; Takeshima Y; Nishio H; Matsuo M
Kobe J Med Sci; 2011 Jul; 57(1):E26-31. PubMed ID: 22169899
[TBL] [Abstract][Full Text] [Related]
10. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.
Xu CF; Reck BH; Xue Z; Huang L; Baker KL; Chen M; Chen EP; Ellens HE; Mooser VE; Cardon LR; Spraggs CF; Pandite L
Br J Cancer; 2010 Apr; 102(9):1371-7. PubMed ID: 20389299
[TBL] [Abstract][Full Text] [Related]
11. UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.
Skierka JM; Kotzer KE; Lagerstedt SA; O'Kane DJ; Baudhuin LM
J Pediatr; 2013 Jun; 162(6):1146-52, 1152.e1-2. PubMed ID: 23290513
[TBL] [Abstract][Full Text] [Related]
12. [Mutation analysis of UGT1A1 gene in patients with unconjugated hyperbilirubinemia].
Sun SC; Zhou ZM; Chen QR; Peng YS; Tu CQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):425-8. PubMed ID: 23926009
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.
Takeuchi K; Kobayashi Y; Tamaki S; Ishihara T; Maruo Y; Araki J; Mifuji R; Itani T; Kuroda M; Sato H; Kaito M; Adachi Y
J Gastroenterol Hepatol; 2004 Sep; 19(9):1023-8. PubMed ID: 15304120
[TBL] [Abstract][Full Text] [Related]
14. Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review.
Culley CL; Kiang TK; Gilchrist SE; Ensom MH
Ann Pharmacother; 2013 Apr; 47(4):561-72. PubMed ID: 23548653
[TBL] [Abstract][Full Text] [Related]
15. UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib.
Meza-Junco J; Chu QS; Christensen O; Rajagopalan P; Das S; Stefanyschyn R; Sawyer MB
Cancer Chemother Pharmacol; 2009 Dec; 65(1):1-4. PubMed ID: 19672597
[TBL] [Abstract][Full Text] [Related]
16. Predicting the risk of sporadic elevated bilirubin levels and diagnosing Gilbert's syndrome by genotyping UGT1A1*28 promoter polymorphism.
Rauchschwalbe SK; Zühlsdorf MT; Schühly U; Kuhlmann J
Int J Clin Pharmacol Ther; 2002 Jun; 40(6):233-40. PubMed ID: 12078936
[TBL] [Abstract][Full Text] [Related]
17. Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients.
Nomura A; Maruo Y; Taga T; Takeuchi Y
Pediatr Res; 2016 Aug; 80(2):252-7. PubMed ID: 27057738
[TBL] [Abstract][Full Text] [Related]
18. Role of UGT1A1 mutation in fasting hyperbilirubinemia.
Ishihara T; Kaito M; Takeuchi K; Gabazza EC; Tanaka Y; Higuchi K; Ikoma J; Watanabe S; Sato H; Adachi Y
J Gastroenterol Hepatol; 2001 Jun; 16(6):678-82. PubMed ID: 11422622
[TBL] [Abstract][Full Text] [Related]
19. Exome-Wide Association Study Identifies New Low-Frequency and Rare UGT1A1 Coding Variants and UGT1A6 Coding Variants Influencing Serum Bilirubin in Elderly Subjects: A Strobe Compliant Article.
Oussalah A; Bosco P; Anello G; Spada R; Guéant-Rodriguez RM; Chery C; Rouyer P; Josse T; Romano A; Elia M; Bronowicki JP; Guéant JL
Medicine (Baltimore); 2015 Jun; 94(22):e925. PubMed ID: 26039129
[TBL] [Abstract][Full Text] [Related]
20. Genetic lesions in the UGT1A1 genes among Gilbert's syndrome patients from India.
Chiddarwar AS; D'Silva SZ; Colah RB; Ghosh K; Mukherjee MB
Mol Biol Rep; 2018 Dec; 45(6):2733-2739. PubMed ID: 30105552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
